Baron Opportunity Fund Inst Shs
Not enough financial coverage to compute a composite score for BIOIX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.baroncapitalgroup.com/product-detail/baron-opportunity-fund-bioix
The fund invests primarily in equity securities in the form of common stock of U. S. high growth businesses of any market capitalization selected for their capital appreciation potential.
- IPO
- 2009
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $1.82B
- Div Yield
- 3.73%
Performance & Tape
- 52W High
- $62.71
- 52W Low
- $50.19
- 50D MA
- $56.95
- 200D MA
- $57.25
- Beta
- 1.27
- Avg Volume
- 0
Get TickerSpark's AI analysis on BIOIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIOIX Coverage
We haven't published any research on BIOIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIOIX Report →